Home NDC 50390-705 Peter Island Sunscreen
Product NDC 50390-705
11-digit product format 503900705
Labeler code 50390
Product ID 50390-705_d6626f99-360b-407c-ad4a-c9a9f9258e3c
Type HUMAN OTC DRUG
Nonproprietary name HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE
Dosage form LOTION
Route TOPICAL
Labeler AMWAY CORP.
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2012-11-26
Marketing end 0000-00-00
Substance HOMOSALATE; OXYBENZONE; AVOBENZONE; OCTISALATE; OCTOCRYLENE
Active strength 10 g/100g; g/100g; g/100g; g/100g; g/100g
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50390-705-56 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50390-705-56 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50390-705-56 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50390-705-56 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50390-705-56 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50390-705-56 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50390-705-56 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50390-705-56 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50390-705-56 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 50390-705-56 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 50390-705-56 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 50390-705-56 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 50390-705-56 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 50390-705-56 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 50390-705-56 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 50390-705-56 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 50390-705-56 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 50390-705-56 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 50390-705-56 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 50390-705-56 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 50390-705-56 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 50390-705-56 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50390-705-56 Peter Island SunscreenSPF 30 226 g in 1 BOTTLE, PLASTIC LOTION 226 3
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AVOBENZONE ACTIVE INGREDIENT G63QQF2NOX PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 HOMOSALATE ACTIVE INGREDIENT V06SV4M95S PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 OCTISALATE ACTIVE INGREDIENT 4X49Y0596W PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 OCTOCRYLENE ACTIVE INGREDIENT 5A68WGF6WM PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 OXYBENZONE ACTIVE INGREDIENT 95OOS7VE0Y PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 AVOBENZONE ACTIVE MOIETY G63QQF2NOX PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 HOMOSALATE ACTIVE MOIETY V06SV4M95S PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 OCTISALATE ACTIVE MOIETY 4X49Y0596W PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 OCTOCRYLENE ACTIVE MOIETY 5A68WGF6WM PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 OXYBENZONE ACTIVE MOIETY 95OOS7VE0Y PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 ALOE VERA LEAF INACTIVE INGREDIENT ZY81Z83H0X PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 BARIUM SULFATE INACTIVE INGREDIENT 25BB7EKE2E PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 JOJOBA OIL INACTIVE INGREDIENT 724GKU717M PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 MINERAL OIL INACTIVE INGREDIENT T5L8T28FGP PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 SORBITAN ISOSTEARATE INACTIVE INGREDIENT 01S2G2C1E4 PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 SORBITOL INACTIVE INGREDIENT 506T60A25R PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 TOCOPHEROL INACTIVE INGREDIENT R0ZB2556P8 PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 TROLAMINE INACTIVE INGREDIENT 9O3K93S3TK PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 WATER INACTIVE INGREDIENT 059QF0KO0R PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50390-705 PETER ISLAND SUNSCREEN SPF 30 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.] 3 Legacy NDC, 1 package rows 20121128_1129b564-ed0f-4372-bc94-eef055b01aee.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 50390-705-56 50390070556 226 g in 1 BOTTLE, PLASTIC 226 g Historical